Work has been undertaken with Illumina over the last 12 months to develop a SNP bead chip that will expand our capacity to screen for mutations associated with MND. The first batch of chips were received early 2022.
Work has been undertaken with Illumina over the last 12 months to develop a SNP bead chip that will expand our capacity to screen for mutations associated with MND. The first batch of chips were received early 2022.